Evidence map›Paper›PMID 36671305›Full record

ReviewAntibiotics (Basel, Switzerland)2023

Advanced Hydrogels Combined with Silver and Gold Nanoparticles against Antimicrobial Resistance.

Yolice Patricia Moreno Ruiz, Luís André de Almeida Campos, Maria Andressa Alves Agreles, André Galembeck, Isabella Macário Ferro Cavalcanti

Open access · goldAbstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Silver and Gold Compounds as Antibiotics.Antibiotics (Basel, Switzerland) · 2024
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yolice Patricia Moreno RuizLaboratory of Microbiology and Immunology, Academic Center of Vitória (CAV), Federal University of Pernambuco (UFPE), Vitória de Santo Antão 55608-680, Pernambuco, Brazil.
Luís André de Almeida CamposLaboratory of Microbiology and Immunology, Academic Center of Vitória (CAV), Federal University of Pernambuco (UFPE), Vitória de Santo Antão 55608-680, Pernambuco, Brazil.
Maria Andressa Alves AgrelesInstitute Keizo Asami (iLIKA), Federal University of Pernambuco (UFPE), Av. Prof. Moraes Rego, 1235, Cidade Universitária, Recife 50670-901, Pernambuco, Brazil.
André GalembeckDepartment of Fundamental Chemistry, Federal University of Pernambuco (UFPE), Av. Jorn. Aníbal Fernandes, Cidade Universitária, Recife 50740-560, Pernambuco, Brazil.
Isabella Macário Ferro CavalcantiLaboratory of Microbiology and Immunology, Academic Center of Vitória (CAV), Federal University of Pernambuco (UFPE), Vitória de Santo Antão 55608-680, Pernambuco, Brazil.
Universidade Federal de Pernambuco · BR

Funding

Fundação de Amparo à Ciência e Tecnologia de Pernambuco APQ-0229-1.06/19Fundação de Amparo à Ciência e Tecnologia de Pernambuco Innovative Scientists 2022 (APQ-0287-4.03/22)National Council for Scientific and Technological Development 316048/2020-8Support for Qualified Production of the Federal University of Pernambuco Propesqi no 09/2021
6 · The paper itself

Abstract

The development of multidrug-resistant (MDR) microorganisms has increased dramatically in the last decade as a natural consequence of the misuse and overuse of antimicrobials. The World Health Organization (WHO) recognizes that this is one of the top ten global public health threats facing humanity today, demanding urgent multisectoral action. The UK government foresees that bacterial antimicrobial resistance (AMR) could kill 10 million people per year by 2050 worldwide. In this sense, metallic nanoparticles (NPs) have emerged as promising alternatives due to their outstanding antibacterial and antibiofilm properties. The efficient delivery of the NPs is also a matter of concern, and recent studies have demonstrated that hydrogels present an excellent ability to perform this task. The porous hydrogel structure with a high-water retention capability is a convenient host for the incorporation of the metallic nanoparticles, providing an efficient path to deliver the NPs properly reducing bacterial infections caused by MDR pathogenic microorganisms. This article reviews the most recent investigations on the characteristics, applications, advantages, and limitations of hydrogels combined with metallic NPs for treating MDR bacteria. The mechanisms of action and the antibiofilm activity of the NPs incorporated into hydrogels are also described. Finally, this contribution intends to fill some gaps in nanomedicine and serve as a guide for the development of advanced medical products.

Indexed as

antibiofilmantibiotic resistancebacterialhydrogelnanotechnology

Identifiers

PMID36671305
PMCPMC9855178
OpenAlexW4313826339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.